Guida M - Search Results

1

Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel.

Gagliardi G, Kandemir O, Liu D, Guida M, Benvestito S, Ruers TG, Benjamin IS, Northover JM, Stamp GW, Talbot IC, et al. Gagliardi G, et al. Among authors: guida m. Virchows Arch. 1995;426(2):149-54. doi: 10.1007/BF00192636. Virchows Arch. 1995. PMID: 7757285

2

[Therapeutic use of rioprostil, 600 micrograms o.d., in duodenal peptic ulcer during its active uncomplicated phase].

Benvestito V, Benvestito S, Guida M, Mariani L. Benvestito V, et al. Among authors: guida m. Minerva Dietol Gastroenterol. 1988 Jul-Sep;34(3):191-5. Minerva Dietol Gastroenterol. 1988. PMID: 3143950 Clinical Trial. Italian. No abstract available.

3

Hepatitis C virus infection in patients with B-cell lymphoproliferative disorders.

Guida M, D'Elia G, Benvestito S, Casamassima A, Micelli G, Quaranta M, Moschetta R, De Lena M, Lorusso V. Guida M, et al. Leukemia. 2002 Oct;16(10):2162-3. doi: 10.1038/sj.leu.2402626. Leukemia. 2002. PMID: 12357374 No abstract available.

4

Metastatic malignant melanoma of the gallbladder: a case report and review of the literature.

Guida M, Cramarossa A, Gentile A, Benvestito S, De Fazio M, Sanbiasi D, Crucitta E, De Lena M. Guida M, et al. Melanoma Res. 2002 Dec;12(6):619-25. doi: 10.1097/00008390-200212000-00012. Melanoma Res. 2002. PMID: 12459652 Review.

5

Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different nosological entities?

Guida M, Casamassima A, Abbate I, Paradiso A, Zito A, Marzullo F, Lorusso V, Timurian A, Cramarossa A, De Lena M. Guida M, et al. Tumori. 1994 Oct 31;80(5):370-7. doi: 10.1177/030089169408000512. Tumori. 1994. PMID: 7839469 Review.

6

Total circulating B lymphocyte abnormalities in a primary cerebral localization of non-Hodgkin lymphoma: a case report.

Guida M, Casamassima A, Marzullo F, Addabbo L, Filotico R, Lorusso V. Guida M, et al. Tumori. 1991 Jun 30;77(3):273-6. doi: 10.1177/030089169107700319. Tumori. 1991. PMID: 1862559

7

Long-term subcutaneous recombinant interleukin-2 as maintenance therapy: biological effects and clinical implications.

Guida M, Abbate I, Casamassima A, Musci MD, Latorre A, Lorusso V, Correale M, De Lena M. Guida M, et al. Cancer Biother. 1995 Fall;10(3):195-203. doi: 10.1089/cbr.1995.10.195. Cancer Biother. 1995. PMID: 8547958 Clinical Trial.

8

Ifosfamide plus mitoxantrone as salvage treatment in non-Hodgkin's lymphomas.

Lorusso V, Paradiso A, Guida M, Berardi F, De Lena M. Lorusso V, et al. Among authors: guida m. Am J Clin Oncol. 1991 Dec;14(6):492-5. doi: 10.1097/00000421-199112000-00007. Am J Clin Oncol. 1991. PMID: 1957837

9

Subcutaneous recombinant interleukin-2 plus alpha interferon and vinblastine in metastatic renal cell carcinoma.

Guida M, Latorre A, Selvaggi F, Ditonno P, Lorusso V, Mastria A, Delena M. Guida M, et al. Int J Oncol. 1997 Mar;10(3):487-91. doi: 10.3892/ijo.10.3.487. Int J Oncol. 1997. PMID: 21533401

10

Effects of subcutaneous recombinant IL-2 on humoral immunity in advanced cancer-patients.

Casamassima A, Guida M, Latorre A, Abbate I, Triantafillou V, Musci M, Delena M. Casamassima A, et al. Among authors: guida m. Int J Oncol. 1993 Aug;3(2):171-6. doi: 10.3892/ijo.3.2.171. Int J Oncol. 1993. PMID: 21573344

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

790 results

Search Page

Filters